Fresenius SE & Co. KGaA (FRE.XETRA)

Exchange: XETRA
Currency: EUR

Price: 32.66 (Close)



52 Week range 200d Moving Avg. Beta
26.69 – 47.60 39.30 1.27
Dividend Dividend Yield Ex-Dividend date
0.92 2.82% 2022-05-16
P/E Ratio Latest EPS DGR 3 years
10.02 3.26 5.47%
High Volatility
Dividend Growth


Fresenius SE & Co. KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment offers dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment specializes in the therapy and care of chronically and critically ill patients. This segment offers IV drugs, including intravenously administered generic anesthetics, analgesics, anti-infectives, and drugs for the treatment of oncological and other critical diseases; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; infusion and nutrition pumps, as well as consumables; and products used in the collection and processing of blood components, as well as in transfusion medicine. The Fresenius Helios segment operates 86 hospitals, 124 outpatient clinics, and 10 prevention centers. The Fresenius Vamed segment manages projects and provides services for hospitals and other health care facilities. This segment offers project development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.


Sector: Industry:
Healthcare Medical Care

Environment, Social and Governance (ESG) Ratings

Total ESG Score

26 – 23 percentile


7 – 7 percentile


12 – 7 percentile


17 – 7 percentile

Controversy level



see MSCI ESG rating explained

Dividend Safety Metrics

Latest EPS 3.26
Annual Payout 0.92
Payout Ratio 28.22%
Dividend growth 28 Years
Dividend Score 84
Dividend Coverage Ratio 3.54
Altman-Z score 0.00


Fresenius SE & Co. KGaA (FRE.XETRA) Valuation

Fresenius SE & Co. KGaA’s current dividend yield of 2.82% is 56% above its 5-year average. The 5-year average dividend yield is 1.80% (see red-line in chart). This indicates the stock may be undervalued today.

Fresenius SE & Co. KGaA (FRE.XETRA) Performance

The chart below displays the total price return(%) of Fresenius SE & Co. KGaA for different periods:


Fresenius SE & Co. KGaA (FRE.XETRA) Total Return

The chart below displays the (CAGR) total return (%) including all dividends paid of Fresenius SE & Co. KGaA for different periods:


Dividend Scorecard

Dividend Yield (TTM) Annual Payout Payout Ratio Dividend growth
2.82 0.92 28.22% 28 Years


Dividend Growth Summary

3 Year Growth Rate (CAGR) 5.47%
5 Year Growth Rate (CAGR) 9.86%
10 Year Growth Rate (CAGR) 11.74%

Dividend Growth Rates History

Year Payout Amount Annual Payout Growth (YoY)
2021 0.880 4.8%
2020 0.840 5.0%
2019 0.800 6.7%
2018 0.750 21.0%
2017 0.620 12.7%
2016 0.550 25.0%
2015 0.440 4.8%
2014 0.420 13.5%
2013 0.370 15.6%
2012 0.320 10.3%
2011 0.290 16.0%
2010 0.250 7.3%
2009 0.233 5.9%
2008 0.220 15.8%

Fresenius SE & Co. KGaA (FRE.XETRA) Dividend Payment History